DOVA - ドバ・ファ―マシュ―ティカルズ (Dova Pharmaceuticals Inc.)

DOVAのニュース

   Dova Pharmaceuticals Enters Overbought Territory: Is A Drop Coming?  2019/10/24 15:40:00 Zacks Investment Research
Dova Pharmaceuticals has moved higher as of late, but there could definitely be trouble on the horizon for this company.
   Dova Pharmaceuticals rallies on buyout offer from Swedish Orphan Biovitrum  2019/09/30 11:10:00 MarketWatch
Dova Pharmaceuticals shares climbed 37% to $27.75 a share in premarket trade after Swedish Orphan Biovitrum said it will buy the company for $27.50 a share…
   Dova Pharmaceuticals (DOVA) Jumps: Stock Rises 8.8%  2019/09/25 12:34:00 Zacks Investment Research
Dova Pharmaceuticals (DOVA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
   Dova Pharmaceuticals (DOVA) Reports Q2 Loss, Lags Revenue Estimates  2019/08/06 13:35:06 Zacks Investment Research
Dova Pharmaceuticals (DOVA) delivered earnings and revenue surprises of -5.26% and -37.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Dova Pharmaceuticals (DOVA) in Focus: Stock Moves 9.1% Higher  2019/07/05 14:09:00 Zacks Investment Research
Dova Pharmaceuticals (DOVA) shares rose more than 9% in the last trading session, amid huge volumes.
   Dova Pharmaceuticals Enters Overbought Territory: Is A Drop Coming?  2019/10/24 15:40:00 Zacks Investment Research
Dova Pharmaceuticals has moved higher as of late, but there could definitely be trouble on the horizon for this company.
   Dova Pharmaceuticals rallies on buyout offer from Swedish Orphan Biovitrum  2019/09/30 11:10:00 MarketWatch
Dova Pharmaceuticals shares climbed 37% to $27.75 a share in premarket trade after Swedish Orphan Biovitrum said it will buy the company for $27.50 a share…
   Dova Pharmaceuticals (DOVA) Jumps: Stock Rises 8.8%  2019/09/25 12:34:00 Zacks Investment Research
Dova Pharmaceuticals (DOVA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
   Dova Pharmaceuticals (DOVA) Reports Q2 Loss, Lags Revenue Estimates  2019/08/06 13:35:06 Zacks Investment Research
Dova Pharmaceuticals (DOVA) delivered earnings and revenue surprises of -5.26% and -37.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Dova Pharmaceuticals (DOVA) in Focus: Stock Moves 9.1% Higher  2019/07/05 14:09:00 Zacks Investment Research
Dova Pharmaceuticals (DOVA) shares rose more than 9% in the last trading session, amid huge volumes.

calendar